Kate J. Newberry
ORCID: 0000-0001-9294-5965
· 1 paper in corpus
article
2016
Abstract Introduction: Anemia is common in MPN-associated myelofibrosis (MF), and current therapies (e.g., erythropoiesis stimulating agents, androgens, danazol, immune modulatory drugs and corticosteroids) are unsatisfactory. Furthermore, …